Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis

References

• Lopalco P. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication[J]. Epidemiol Infect. 2017;145(3):413–9.
   PubMed Web of Science ®Google Scholar
• WHO. Poliomyelitis. [accessed 2018 Apr 10]. http://www.who.int/mediacentre/factsheets/fs114/en/.
   Google Scholar
• Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-Jahi S, Parvaneh L, Mahmoudi S, Chavoshzadeh Z, Yazdani R, Zahraei SM, Ebrahimi M, et al. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995–2014[J]. Emerg Infect Dis. 2016;22(10):1712–9. doi:10.3201/eid2210.151071.
   PubMed Web of Science ®Google Scholar
• Sepúlveda J. Global health: Towards polio eradication[J]. Nature. 2017;547(7664):411–2.
   PubMed Web of Science ®Google Scholar
• Platt LR, Estivariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden[J]. J Infect Dis. 2014;210 Suppl 1:S380–9. doi:10.1093/infdis/jiu184.
   PubMed Web of Science ®Google Scholar
• Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis[J]. Expert Rev Vaccines. 2012;11(5):609–28. doi:10.1586/erv.12.28.
   PubMed Web of Science ®Google Scholar
• Korotkova E, Gmyl A, Yakovenko M, Ivanova O, Eremeeva T, Kozlovskaya L, Shakaryan A, Lipskaya G, Parshina I, Loginovskikh N, et al. A cluster of Paralytic Poliomyelitis cases due to transmission of slightly Diverged Sabin 2 Vaccine Poliovirus[J]. J Virol. 2016;90(13):5978–88.
   PubMed Web of Science ®Google Scholar
• Foiadelli T, Savasta S, Battistone A, Kota M, Passera C, Fiore S, Bino S, Amato C, Lozza A, Marseglia G, et al. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis[J]. BMC Infect Dis. 2016;16:277.
   PubMed Web of Science ®Google Scholar
• Etsano A, Damisa E, Shuaib F, Nganda G, Enemaku O, Usman S, Adeniji A, Jorba J, Iber J, Ohuabunwo C, et al. Environmental isolation of circulating Vaccine-Derived Poliovirus after interruption of Wild Poliovirus Transmission – Nigeria, 2016[J]. MMWR Morb Mortal Wkly Rep. 2016;65(30):770–3.
   PubMed Web of Science ®Google Scholar
• Pons-Salort M, Burns C, Lyons H, Blake I, Jafari H, Oberste M, Kew O, Grassly N. Preventing Vaccine-Derived Poliovirus emergence during the Polio Endgame[J]. PLoS Pathog. 2016;12(7):e1005728.
   PubMed Web of Science ®Google Scholar
• GPEI-Global Polio Eradication Initiative. [accessed 2018 Apr 12]. http://polioeradication.org/.
   Google Scholar
• Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine[J]. Expert Rev Vaccines. 2015;14(5):749–62. doi:10.1586/14760584.2015.1001750.
   PubMed Web of Science ®Google Scholar
• Abramson JS, Baker CJ, Fisher MC, Gerber MA, Meissner HC, Murray DL, Overturf GD, Prober CG, Rennels MB, Saari TN, et al. Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization[J]. Pediatrics. 1999;104(6):1404–6. doi:10.1542/peds.104.6.1404.
   PubMed Web of Science ®Google Scholar
• Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States[J]. Jama. 2004;292(14):1696–701.
   PubMed Web of Science ®Google Scholar
• Parker EPK, Molodecky NA, Pons-Salort M, O'Reilly KM, Grassly NC. Impact of inactivated poliovirus vaccine on mucosal immunity: Implications for the polio eradication endgame[J]. Expert Rev Vaccines. 2015;14(8):1113–23. doi:10.1586/14760584.2015.1052800.
   PubMed Web of Science ®Google Scholar
• Kraan H, van der Stel W, Kersten G, Amorij JP. Alternative administration routes and delivery technologies for polio vaccines[J]. Expert Rev Vaccines. 2016;15(8):1029–40. doi:10.1586/14760584.2016.1158650.
   PubMed Web of Science ®Google Scholar
• Hamidi A, Bakker WAM. Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains[J]. Pharm Pat Anal. 2012;1(5):589–99. doi:10.4155/ppa.12.70.
   PubMedGoogle Scholar
• Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, Okiror S, Abrar L, Nasibov O, Burton J, et al. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities – Kenya, December 2013[J]. MMWR Morb Mortal Wkly Rep. 2014;63(11):237–41. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L372961210.
   PubMed Web of Science ®Google Scholar
• Gavi, the Vaccine Alliance: Gavi's impact. [accessed 2018 Apr 12]. http://www.gavi.org/support/nvs/inactivated-polio-vaccine.
   Google Scholar
• Saez-Llorens X, Clemens R, Leroux-Roels G, Jimeno J, Clemens SA, Weldon WC, Oberste MS, Molina N, Bandyopadhyay AS. Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial[J]. Lancet Infect Dis. 2016;16(3):321–30. doi:10.1016/S1473-3099(15)00488-0.
   PubMed Web of Science ®Google Scholar
• Organization WH. Polio vaccines: WHO position paper – March, 2016[J]. Wkly Epidemiol Rec. 2016;91(12):145–68.
   PubMedGoogle Scholar
• Organizition WH. Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013–2016[J]. Wkly Epidemiol Rec. 2015;90(27):337–43. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L606055009.
   PubMedGoogle Scholar
• Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses[J]. J Infect Dis. 1990;162(6):1291–7. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L21001210.
   PubMed Web of Science ®Google Scholar
• Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M, Chumakov K, Halsey NA. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants[J]. J Infect Dis. 2007;196(5):692–8. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/656/CN-00703656/frame.html.
   PubMed Web of Science ®Google Scholar
• Liu HB, Lin JP, Wu YH, Liang H. Serological responses following primary immunization with poliomyelitis vaccine by various schedules[J]. Chinese Journal of Biologicals. 2013;26(11):1641–3. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L372150217.
   Google Scholar
• Zhang LW, Xu Y, Xing HY, Wang HH, Yuan XH, Zhu ZL. Evaluation of immune effects of primary and booster immunizations with inactivated and oral polio vaccines by various sequential programs in Changping District, Beijing City, China[J]. Chinese Journal of Biologicals. 2014;27(10):1283–7. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L601832225.
   Google Scholar
• Lu L, Li X, Zhang H, Liu D, Zhang Z, Wang H, Liu F, Ning Z, Li J, Pang X. Immunogenicity and persistence from different 3-dose schedules of live and inactivated polio vaccines in Chinese infants[J]. Vaccine. 2015;33(36):4653–8.
   PubMed Web of Science ®Google Scholar
• O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, et al. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study[J]. Lancet Infect Dis. 2015;15(11):1273–82. doi:10.1016/S1473-3099(15)00219-4.
   PubMed Web of Science ®Google Scholar
• Lu L, Li XM, Liu DL, Zhang HR, Zhang ZJ, Wang HH, Liu F, Ning ZQ, Zhang LW, Chu P, et al. Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine[J]. Zhonghua yu Fang yi Xue za Zhi. 2012;46(6):510–3. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L366400664.
   PubMedGoogle Scholar
• Faden H, Duffy L, Sun M, Shuff C. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines[J]. J Infect Dis. 1993;168(2):452–4.
   PubMed Web of Science ®Google Scholar
• Greenwood BM, Hall AJ, Rowe MG, Whittle HC, George M, Al-Ghassani AAK, Elbualy M, Malankar PG, Suleiman AJM, Clements GB, et al. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. Bull World Health Organ. 1996;74(3):253–68. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/252/CN-00405252/frame.html.
   PubMed Web of Science ®Google Scholar
• Robertson SE. Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand[J]. J Infect Dis. 1997;175(2 SUPPL.):S215–S27. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L27053513.
   PubMedGoogle Scholar
• Sutter RW, Suleiman AJ, Malankar PG, Mehta FR, Medany MA, Arif MA, Linkins RW, Pallansch MA, El-Bualy MS, Robertson SE. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman[J]. J Infect Dis. 1997;175 Suppl1:S235–40. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L27053515.
   Web of Science ®Google Scholar
• Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group[J]. J Infect Dis. 1997;175 Suppl 1:S228–34. http://www.embase.com/search/results?subaction = viewrecord&from = export&id = L27053514.
   PubMed Web of Science ®Google Scholar
• Anand A, Zaman K, Estivariz CF, Yunus M, Gary HE, Weldon WC, Bari TI, Steven Oberste M, Wassilak SG, Luby SP, et al. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial[J]. Vaccine. 2015;33(48):6816–22. doi:10.1016/j.vaccine.2015.09.039.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay AS, Garon J, Seib K, Orenstein WA. Polio vaccination: Past, present and future[J]. Future Microbiol. 2015;10(5):791–808. doi:10.2217/fmb.15.19.
   PubMed Web of Science ®Google Scholar
• Polio Eradication and Endgame Strategic Plan 2013-“2018. [accessed 2018 Apr 15]. http://www.polioeradication.org/Portals/0/Document/Resources/.
   Google Scholar
• Okayasu H, Sutter RW, Jafari HS, Takane M, Aylward RB. Affordable inactivated poliovirus vaccine: strategies and progress[J]. J Infect Dis. 2014;210 Suppl 1:S459–64.
   PubMed Web of Science ®Google Scholar
• Resik S, Tejeda A, Mach O, Sein C, Molodecky N, Jarrahian C, Saganic L, Zehrung D, Fonseca M, Diaz M, et al. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity [J]. Vaccine. 2015;33(43):5873–7. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/739/CN-01170739/frame.html.
   PubMed Web of Science ®Google Scholar
• Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter R. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba[J]. Vaccine. 2015;33(2):307–13. doi:10.1016/j.vaccine.2014.11.025.
   PubMed Web of Science ®Google Scholar
• Anand A, Molodecky NA, Pallansch MA, Sutter RW. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule[J]. Vaccine. 2017;35(22):2993–8.
   PubMed Web of Science ®Google Scholar
• Rivera L, Pedersen R, Peña L, Olsen K, Andreasen L, Kromann I, Nielsen PI, Sørensen C, Dietrich J, Bandyopadhyay AS, et al. Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial[J]. Lancet Infect Dis. 2017;17(7):745–53.
   PubMed Web of Science ®Google Scholar
• Galindo M, Lago PM, Cáceres V, Landaverde M, Sutter R. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba[J]. N Engl J Med. 2007;356(15):1536–44. doi:10.1056/NEJMoa054960.
   PubMed Web of Science ®Google Scholar
• John J, Giri S, Karthikeyan A, Lata D, Jeyapaul S, Rajan A, Kumar N, Dhanapal P, Venkatesan J, Mani M, et al. The duration of intestinal Immunity after an inactivated Poliovirus Vaccine Booster Dose in Children immunized with Oral Vaccine: A randomized Controlled Trial[J]. J Infect Dis. 2017;215(4):529–36.
   PubMed Web of Science ®Google Scholar
• John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, Grassly NC, Kang G. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial[J]. Lancet. 2014;384(9953):1505–12. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/495/CN-01022495/frame.html.
   PubMed Web of Science ®Google Scholar
• Asturias EJ, Bandyopadhyay AS, Self S, Rivera L, Saez-Llorens X, Lopez E, Melgar M, Gaensbauer JT, Weldon WC, Oberste MS, et al. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial[J]. Lancet. 2016;388(10040):158–69. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/932/CN-01167932/frame.html.
   PubMed Web of Science ®Google Scholar
• Sutter RW, Bahl S, Deshpande JM, Verma H, Ahmad M, Venugopal P, Rao JV, Agarkhedkar S, Lalwani SK, Kunwar A, et al. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial[J]. Lancet. 2015;386(10011):2413–21. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/547/CN-01108547/frame.html.
   PubMed Web of Science ®Google Scholar
• Saleem AF, Mach O, Quadri F, Khan A, Bhatti Z, Rehman NU, Zaidi S, Weldon WC, Oberste SM, Salama M, et al. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan[J]. Vaccine. 2015;33(24):2757–63. doi:10.1016/j.vaccine.2015.04.055.
   PubMed Web of Science ®Google Scholar
• Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review[J]. Lancet Respir Med. 2018;6(3):223–30.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S. Assessing risk of bias in included studies. http://handbook.cochrane.org/. [updated March 2011].
   Google Scholar
• Tang G, Yin W, Liu W. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?[J]. Diagn Microbiol Infect Dis. 2017;88(4):322–9.
   PubMed Web of Science ®Google Scholar
• Chambers DRM, Woolacott N. Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies[J]. J Clin Epidemiol. 2009;62(12):1253–60.e4.
   PubMed Web of Science ®Google Scholar